Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme 1 selected

Guidance programme

Showing 781 to 790 of 881

TitleReference numberPublishedLast updated
Targeted-release budesonide for treating primary IgA nephropathyTA1128
Tarlatamab for extensive-stage small-cell lung cancer after 2 or more treatmentsTA1091
Tebentafusp for treating advanced uveal melanomaTA1027
Teclistamab for treating relapsed and refractory multiple myeloma after 3 or more treatmentsTA1015
Teduglutide for treating short bowel syndromeTA804
Telbivudine for the treatment of chronic hepatitis BTA154
Temsirolimus for the treatment of relapsed or refractory mantle cell lymphoma (terminated appraisal)TA207
Tenecteplase for treating acute ischaemic strokeTA990
Tenofovir alafenamide for treating chronic hepatitis B (terminated appraisal)TA435
Tenofovir disoproxil for the treatment of chronic hepatitis BTA173

Results per page

  1. 10
  2. 25
  3. 50
  4. All